Linked Life Data

11998784

Source:http://linkedlifedata.com/resource/pubmed/id/11998784

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-5-9
pubmed:abstractText
Tat is a key trans-activator of HIV-1 gene transcription and major progress has been accomplished in recent years in regard to understanding its mechanism of action. An important breakthrough was the identification of the TAR-Tat-Cyclin (Cyc) T1-Cyclin-dependent kinase 9 (CDK9) complex, in which CDK9 can hyperphosphorylate the carboxyl-terminus domain (CTD) of the RNA polymerase (RNAP) II complex. A different activity of Tat has recently been identified in reverse transcription. Notably, mutated HIV-1 that lacks a functional Tat protein cannot efficiently generate reverse transcription products following infection of permissive cells. Furthermore, Tat can also inhibit reverse transcriptase activity in cell-free assays and can act as a suppressor of reverse transcription at late stages in the viral life cycle. This suppressor activity of Tat can restrict the premature reverse transcription of viral RNA in the cytoplasm and allows the viral genome to be packaged as intact RNA molecules.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1139-6121
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
41-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
The role of Tat in HIV-1 replication: an activator and/or a suppressor?
pubmed:affiliation
McGill AIDS Centre, Lady Davis Institute-Jewish General Hospital, 3755 Cote Ste Catherine Road, Montreal, Quebec, Canada H3T 1E2. mark.wainberg@mcgill.ca
pubmed:publicationType
Journal Article, Review